216 related articles for article (PubMed ID: 26172282)
21. Pharmacokinetic and pharmacodynamic data from the NEOLEV1 and NEOLEV2 studies.
Sharpe C; Yang DZ; Haas RH; Reiner GE; Lee L; Capparelli EV;
Arch Dis Child; 2024 Jun; ():. PubMed ID: 38902005
[TBL] [Abstract][Full Text] [Related]
22. Forecasting Fetal Buprenorphine Exposure through Maternal-Fetal Physiologically Based Pharmacokinetic Modeling.
van Hoogdalem MW; Tanaka R; Abduljalil K; Johnson TN; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543269
[TBL] [Abstract][Full Text] [Related]
23. Gender differences in pharmacokinetics of maintenance dosed buprenorphine.
Moody DE; Fang WB; Morrison J; McCance-Katz E
Drug Alcohol Depend; 2011 Nov; 118(2-3):479-83. PubMed ID: 21515002
[TBL] [Abstract][Full Text] [Related]
24. Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates.
Samiee-Zafarghandy S; van Donge T; Allegaert K; van den Anker J
Children (Basel); 2021 Feb; 8(3):. PubMed ID: 33668712
[TBL] [Abstract][Full Text] [Related]
25. The Finnegan Score for Neonatal Opioid Withdrawal Revisited With Routine Electronic Data: Retrospective Study.
Rech T; Rubarth K; Bührer C; Balzer F; Dame C
JMIR Pediatr Parent; 2024 Feb; 7():e50575. PubMed ID: 38456232
[TBL] [Abstract][Full Text] [Related]
26. Considerations for pharmacokinetic assessment of immunoglobulins: Gammagard in very low birth weight neonates with and without baseline-correction.
Mahmood I; Tegenge MA; Golding B
Int Immunopharmacol; 2020 Mar; 82():106358. PubMed ID: 32135491
[TBL] [Abstract][Full Text] [Related]
27. Barriers and Challenges in Performing Pharmacokinetic Studies to Inform Dosing in the Neonatal Population.
O'Hara K; Martin JH; Schneider JJ
Pharmacy (Basel); 2020 Feb; 8(1):. PubMed ID: 32033361
[TBL] [Abstract][Full Text] [Related]
28. Why population pharmacokinetic studies are instrumental to boost clinical research in neonates, and suggestions on how clinicians should assess these papers.
Li Y; Allegaert K
Pediatr Res; 2024 Apr; 95(5):1181-1183. PubMed ID: 38195936
[No Abstract] [Full Text] [Related]
29. A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.
Hall ES; Isemann BT; Wexelblatt SL; Meinzen-Derr J; Wiles JR; Harvey S; Akinbi HT
J Pediatr; 2016 Mar; 170():39-44.e1. PubMed ID: 26703873
[TBL] [Abstract][Full Text] [Related]
30. Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.
Kraft WK; Stover MW; Davis JM
Semin Perinatol; 2016 Apr; 40(3):203-12. PubMed ID: 26791055
[TBL] [Abstract][Full Text] [Related]
31. Interim buprenorphine treatment in opiate dependence: A pilot effectiveness study.
Abrahamsson T; Widinghoff C; Lilliebladh A; Gedeon C; Nilvall K; Hakansson A
Subst Abus; 2016; 37(1):104-9. PubMed ID: 26176490
[TBL] [Abstract][Full Text] [Related]
32. Injecting buprenorphine-naloxone film: Findings from an explorative qualitative study.
White N; Flaherty I; Higgs P; Larance B; Nielsen S; Degenhardt L; Ali R; Lintzeris N
Drug Alcohol Rev; 2015 Nov; 34(6):623-9. PubMed ID: 26179339
[TBL] [Abstract][Full Text] [Related]
33. Neonatal Abstinence Syndrome - Diagnostic Dilemmas in the Maternity Ward.
Lazić Mitrović T; Miković Ž; Mandić V; Avramović LH; Ćećez D; Stanimirović A; Janković B
Srp Arh Celok Lek; 2015; 143(9-10):573-7. PubMed ID: 26727865
[TBL] [Abstract][Full Text] [Related]
34. Rapamycin ameliorates cadmium-induced activation of MAPK pathway and neuronal apoptosis by preventing mitochondrial ROS inactivation of PP2A.
Xu C; Wang X; Zhu Y; Dong X; Liu C; Zhang H; Liu L; Huang S; Chen L
Neuropharmacology; 2016 Jun; 105():270-284. PubMed ID: 26805420
[TBL] [Abstract][Full Text] [Related]
35. Tramadol-Paracetamol Combination for Postoperative Pain Relief in Elective Single-level Microdisectomy Surgery.
Dogar SA; Khan FA
J Neurosurg Anesthesiol; 2017 Apr; 29(2):157-160. PubMed ID: 26797106
[TBL] [Abstract][Full Text] [Related]
36. Comparative Study Between Lidocaine Gel 2% and 5% for Ophthalmic Procedures.
Shiroma HF; Shimono KE; Farah ME; Goldhardt R; Grumann A; Rodrigues EB
J Ocul Pharmacol Ther; 2016 May; 32(4):192-5. PubMed ID: 26790036
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies.
Adams DM; Trenor CC; Hammill AM; Vinks AA; Patel MN; Chaudry G; Wentzel MS; Mobberley-Schuman PS; Campbell LM; Brookbank C; Gupta A; Chute C; Eile J; McKenna J; Merrow AC; Fei L; Hornung L; Seid M; Dasgupta AR; Dickie BH; Elluru RG; Lucky AW; Weiss B; Azizkhan RG
Pediatrics; 2016 Feb; 137(2):e20153257. PubMed ID: 26783326
[TBL] [Abstract][Full Text] [Related]
38. Fulminant Peripartum myocarditis associated with sudden cardiac death: a case report.
Ciccone MM; Dentamaro I; Carbonara S; Ricci G; Vestito D; Marzullo A; Tunzi F; Solarino B
Cardiovasc Pathol; 2016; 25(2):87-9. PubMed ID: 26764139
[TBL] [Abstract][Full Text] [Related]
39. Safety of a short hydration method for cisplatin administration in comparison with a conventional method-a retrospective study.
Sakaida E; Iwasawa S; Kurimoto R; Ebata T; Imai C; Oku T; Sekine I; Tada Y; Tatsumi K; Takiguchi Y
Jpn J Clin Oncol; 2016 Apr; 46(4):370-7. PubMed ID: 26755829
[TBL] [Abstract][Full Text] [Related]
40. Impact of Melatonin on Motor, Cognitive and Neuroimaging Indices in Patients with Multiple Sclerosis.
Roostaei T; Sahraian MA; Hajeaghaee S; Gholipour T; Togha M; Siroos B; Mansouri S; Mohammadshirazi Z; Aghazadeh Alasti M; Harirchian MH
Iran J Allergy Asthma Immunol; 2015 Dec; 14(6):589-95. PubMed ID: 26725556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
